Researcher Profiles

All Members

Search by Name (ALL MEMBERS)

Last Name: and/or First Name:

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

Joseph Aisner, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Seena C. Aisner, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Ayse Akincigil, PhD
Associate II Member,
Cancer Prevention and Control Program

Lauren M. Aleksunes, PharmD, PhD, DABT
Full Member,
Clinical Investigations and Precision Therapeutics Program

Peter S. Amenta, MD, PhD
Associate II Member,
Program: non-aligned

Judith Korek Amorosa, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Tracy G. Anthony, PhD
Full Member,
Cancer Metabolism and Growth Program

Shawn M. Arent, MS, PhD
Associate II Member,
Cancer Prevention and Control Program

Edward Arnold, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

David J. Augeri, PhD
Associate II Member,
Cancer Metabolism and Growth Program,
Cancer Pharmacology Program

David A. August, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Robert H. Austin, PhD
Full Member,
Cancer Metabolism and Growth Program

Hana A. Aviv, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

David E. Axelrod, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Manisha Bajpai, PhD
Associate II Member,
Cancer Pharmacology Program

Elisa V. Bandera, MD, PhD
Full Member,
Cancer Prevention and Control Program

Debabrata Banerjee, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Rajat Bannerji, MD, PhD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Nicola J. Barnard, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Beverly E. Barton, PhD
Associate II Member,
Program: non-aligned

Joseph R. Bertino, MD
Full Member,
Cancer Pharmacology Program

Sharathkumar M. Bhagavathi, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Gyan Bhanot, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Mantu Bhaumik, PhD
Advisory Member,
Program: non-aligned

Raymond B. Birge, PhD
Full Member,
Cancer Metabolism and Growth Program

Nada N. Boustany, PhD
Full Member,
Cancer Metabolism and Growth Program

Neal R. Boyd, EdD, MSPH
Associate II Member,
Cancer Prevention and Control Program

Kenneth J. Breslauer, PhD
Associate II Member,
Program: non-aligned

Gary A. Brewer, PhD
Full Member,
Program: non-aligned

Steven J. Brill, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Yana Bromberg, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Diane R. Brown, PhD
Associate II Member,
Cancer Prevention and Control Program

Michael D. Bui, DDS, MPH, JD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Samuel F. Bunting, MBiochem, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Stephen K. Burley, MD, DPhil
Full Member,
Cancer Pharmacology Program

Li Cai, PhD
Associate I Member,
Cancer Metabolism and Growth Program

Darren R. Carpizo, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program,
Cancer Pharmacology Program

Kiran K. Chada, Dphil (Oxon)
Associate II Member,
Genome Instability and Cancer Genetics Program

Chang S. Chan, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Sheenu Chandwani, BDS, PhD
Associate II Member,
Cancer Prevention and Control Program

Gretchen Chapman, PhD
Associate II Member,
Cancer Prevention and Control Program

J. Don Chen, PhD
Associate II Member,
Program: non-aligned

Kuang-Yu Chen, PhD
Associate II Member,
Program: non-aligned

Suzie Chen, PhD
Full Member,
Cancer Pharmacology Program

Ting Chen, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Allison H. Christian, EdD, CHES
Associate II Member,
Cancer Prevention and Control Program

David I. Cohen, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Karine A. Cohen-Solal, PhD
Full Member,
Cancer Metabolism and Growth Program

Wendie S. Cohick, PhD
Associate II Member,
Program: non-aligned

Alan Cohler, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Nina A. Cooperman, PsyD
Associate II Member,
Cancer Prevention and Control Program

Paul R. Copeland, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Elliot J. Coups, PhD
Full Member,
Cancer Prevention and Control Program

Lori R. Covey, PhD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Benjamin F. Crabtree, PhD
Full Member,
Cancer Prevention and Control Program

Shabbar F. Danish, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Kiron M. Das, MD, PhD, FACP, FRCP
Full Member,
Clinical Investigations and Precision Therapeutics Program

Kevin A. David, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Tomer Davidov, MD, FACS
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Christine M. Davis, PhD
Associate II Member,
Cancer Prevention and Control Program

Cristine D. Delnevo, PhD, MPH
Full Member,
Cancer Prevention and Control Program

Kitaw Demissie, MD, PhD
Full Member,
Cancer Prevention and Control Program

Lisa K. Denzin, PhD
Full Member,
Cancer Metabolism and Growth Program

Danelle Devenport, MSc, PhD
Full Member,
Cancer Metabolism and Growth Program

Katie Devine, PhD, MPH
Associate I Member,
Cancer Prevention and Control Program

Robert S. DiPaola, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Richard A. Drachtman, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Cheryl F. Dreyfus, PhD
Full Member,
Cancer Metabolism and Growth Program

Monica A. Driscoll, PhD
Full Member,
Cancer Metabolism and Growth Program

Sandra E. Echeverria, PhD
Associate II Member,
Cancer Prevention and Control Program

Paul G. Falkowski, PhD
Full Member,
Cancer Metabolism and Growth Program

Huizhou Fan, MD, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Mingzhu Fang, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Zhaohui Feng, MD, PhD
Full Member,
Cancer Metabolism and Growth Program

Jeanne M. Ferrante, MD, MPH, FAAFP
Full Member,
Cancer Prevention and Control Program

Patricia A. Findley, DrPH, MSW
Associate II Member,
Cancer Prevention and Control Program

Patricia A. Fitzgerald-Bocarsly, PhD
Full Member,
Cancer Metabolism and Growth Program

Joseph D. Fondell, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

David J. Foran, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Ramsey A. Foty, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Philip Furmanski, PhD
Associate II Member,
Program: non-aligned

Molly Gabel, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Michael A. Gallo, PhD
Advisory Member,
Program: non-aligned

Alison E. Gammie, PhD
Associate I Member,
Genome Instability and Cancer Genetics Program

Shridar Ganesan, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Nan Gao, PhD
Full Member,
Cancer Metabolism and Growth Program

Marc R. Gartenberg, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Celine Gelinas, PhD
Associate II Member,
Program: non-aligned

Panos G. Georgopoulos, PhD
Associate II Member,
Program: non-aligned

Mecide M. Gharibo, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Darlene G. Gibbon, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Peter J. Gillies, PhD, FAHA
Full Member,
Cancer Metabolism and Growth Program

Gary S. Goldberg, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Lauri Goodell, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Susan Goodin, PharmD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Andrew Gow, PhD
Full Member,
Cancer Metabolism and Growth Program

Sharad Goyal, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

James S. Goydos, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Judith M. Graber, PhD
Associate II Member,
Cancer Prevention and Control Program

John J. Graff, PhD, MS
Associate II Member,
Cancer Prevention and Control Program

Kathryn L. Greene, PhD, MA
Associate II Member,
Cancer Prevention and Control Program

Samuel I. Gunderson, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Grace L. Guo, MBBS, PhD
Full Member,
Cancer Metabolism and Growth Program

Bruce G. Haffty, MD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Beatrice Haimovich, PhD
Associate II Member,
Cancer Metabolism and Growth Program

William Halperin, Dr.P.H., M.D., M.P.H.
Associate II Member,
Cancer Prevention and Control Program

Michael Hampsey, PhD
Associate II Member,
Program: non-aligned

Simon J. Hanft, MD, Mphil
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Daniel Hart, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Ronald P. Hart, PhD
Full Member,
Cancer Metabolism and Growth Program

Arash Hatefi, PharmD, PhD
Associate I Member,
Cancer Pharmacology Program

Mira Hellman, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Utz Herbig, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Karl Herrup, PhD
Associate I Member,
Genome Instability and Cancer Genetics Program

Kim M. Hirshfield, MD, PhD
Associate I Member,
Genome Instability and Cancer Genetics Program

Jun-Yan Hong, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Mary Hrywna, MPH
Associate II Member,
Cancer Prevention and Control Program

Henry C. Hsia, MD
Associate II Member,
Cancer Metabolism and Growth Program

Longqin Hu, PhD
Associate II Member,
Cancer Pharmacology Program

Wenwei Hu, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Shawna V. Hudson, PhD
Full Member,
Cancer Prevention and Control Program

Masayori Inouye, PhD
Associate II Member,
Program: non-aligned

Kenneth D. Irvine, PhD
Full Member,
Cancer Metabolism and Growth Program

Sara S. Isani, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Kosaku Iwatsubo, MD, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Salma Jabbour, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Estela Jacinto, PhD
Full Member,
Cancer Metabolism and Growth Program

Shengkan (Victor) Jin, PhD
Associate II Member,
Cancer Pharmacology Program

Roger A. Jones, PhD
Associate II Member,
Program: non-aligned

Leonid Kagan, PhD
Associate II Member,
Cancer Pharmacology Program

Yibin Kang, PhD
Full Member,
Cancer Metabolism and Growth Program

Howard L. Kaufman, MD, FACS
Full Member,
Clinical Investigations and Precision Therapeutics Program

Neerja Kaushik-Basu, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Thomas J. Kearney, MD, FACS
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

John E. Kerrigan, PhD
Associate II Member,
Cancer Pharmacology Program

Atif J. Khan, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Megerditch (Mike) Kiledjian, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Isaac Yi Kim, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Leonard H. Kim, MS, AMusD, DABR
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sung Kim, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

S. David Kimball, PhD
Associate II Member,
Cancer Pharmacology Program

Terri Goss Kinzy, PhD
Associate I Member,
Program: non-aligned

Howard M. Kipen, MD, MPH
Associate II Member,
Cancer Prevention and Control Program

Laurie J. Kirstein, MD, FACS
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Spencer A. Knapp, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Joachim B. Kohn, PhD
Full Member,
Cancer Pharmacology Program

A.-N. Tony Kong, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Vadim Koshenkov, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sunita G. Kramer, PhD
Full Member,
Cancer Metabolism and Growth Program

Muriel W. Lambert, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

John E. Langenfeld, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Amale Laouar, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Ahmed Lasfar, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Debra L. Laskin, PhD
Full Member,
Cancer Metabolism and Growth Program

Jeffrey D. Laskin, PhD
Full Member,
Program: non-aligned

Edmund C. Lattime, PhD
Full Member,
Cancer Metabolism and Growth Program

Edmond J. LaVoie, PhD
Associate II Member,
Cancer Pharmacology Program

Bette Lazzaro, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Paola Leone, PhD
Associate II Member,
Program: non-aligned

Pauline Lerma, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Howard Leventhal, PhD
Associate II Member,
Program: non-aligned

Arnold Levine, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Jocelyn A. Lewis, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

M. Jane Lewis, DrPH
Full Member,
Cancer Prevention and Control Program

Honghua Li, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Shaohua Li, MD
Associate II Member,
Cancer Metabolism and Growth Program

Paul J. Lioy, PhD
Associate II Member,
Program: non-aligned

Alice Y.C. Liu, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Fang Liu, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Adana A. Llanos, PhD, MPH
Associate I Member,
Cancer Prevention and Control Program

Peter Lobel, PhD
Full Member,
Cancer Metabolism and Growth Program

Grace L. Lu-Yao, PhD, MPH
Full Member,
Cancer Prevention and Control Program

Yi Lisa Lyu, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Kiran Madura, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Omar M. Mahmoud, MD, MSc, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sharon L. Manne, PhD
Full Member,
Cancer Prevention and Control Program

Margaret Masterson, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Michael P. Matise, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Tara C. Matise, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Fumio Matsumura, PhD
Full Member,
Cancer Metabolism and Growth Program

Tina M. Mayer, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Danielle E. McCarthy, PhD
Full Member,
Cancer Prevention and Control Program

Kimberly A. McGuigan, PhD, MBA
Associate II Member,
Cancer Prevention and Control Program

Michael McKenna, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Kim S. McKim, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Daniel J. Medina, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Janice M. Mehnert, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Peter W. Melera, PhD
Advisory Member,
Cancer Pharmacology Program

Laleh G. Melstrom, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Qingyu Meng, PhD, MS
Associate II Member,
Cancer Prevention and Control Program

Dimitris N. Metaxas, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Bozena (Bo) B. Michniak-Kohn, PhD, MRPharmS
Associate II Member,
Cancer Pharmacology Program

James H. Millonig, PhD
Associate II Member,
Program: non-aligned

Audrey Minden, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Tamara Minko, PhD
Full Member,
Cancer Pharmacology Program

Prabhas V. Moghe, PhD
Full Member,
Cancer Pharmacology Program

Christopher J. Molloy, PhD, RPh
Associate II Member,
Cancer Pharmacology Program

Gaetano T. Montelione, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Elizabeth Moran, PhD
Associate II Member,
Program: non-aligned

Tricia Morino, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Rebecca Moss, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Sabin Motwani, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Susan M. Murphy, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Venkat Narra, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Celeste M. Nelson, PhD
Full Member,
Cancer Metabolism and Growth Program

Bryce E. Nickels, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Ke Nie, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

John L. Nosher, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Daniel A. Notterman, MD
Full Member,
Cancer Metabolism and Growth Program

Pamela A. Ohman-Strickland, PhD
Advisory Member,
Cancer Prevention and Control Program

Harvey L. Ozer, MD
Full Member,
Program: non-aligned

Richard W. Padgett, PhD
Full Member,
Cancer Metabolism and Growth Program

Wilbur Pan, MD, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Manish Parashar, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Vimal D. Patel, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Mark C. Pierce, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Daniel S. Pilch, PhD
Associate II Member,
Cancer Pharmacology Program

Sharon R. Pine, PhD
Full Member,
Genome Instability and Cancer Genetics Program

John E. Pintar, PhD
Associate II Member,
Program: non-aligned

Vincenzo Pirrotta, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Alexander Ploss, PhD
Full Member,
Cancer Metabolism and Growth Program

Elizabeth A. Poplin, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Xin Qi, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Joshua D. Rabinowitz, MD, PhD
Full Member,
Cancer Metabolism and Growth Program

Arnold B. Rabson, MD
Full Member,
Cancer Metabolism and Growth Program

Pranela Rameshwar, PhD
Associate I Member,
Cancer Pharmacology Program

Babar K. Rao, MD, FAAD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Mladen-Roko Rasin, MD, PhD
Associate II Member,
Program: non-aligned

Yi Ren, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Kenneth R. Reuhl, PhD
Full Member,
Program: non-aligned

George G. Rhoads, MD, MPH
Associate II Member,
Cancer Prevention and Control Program

Roy H. Rhodes, MD, PhD
Associate II Member,
Program: non-aligned

Joseph E. Rice, PhD
Associate I Member,
Cancer Pharmacology Program

Fred S. Roberts, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Joanne P. Robinson, PhD, RN, GCNS-BC, FAAN
Associate II Member,
Cancer Prevention and Control Program

Lorna Rodriguez-Rodriguez, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Marsha Rosenthal, MPA, PhD
Associate II Member,
Program: non-aligned

Monica J. Roth, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Vanessa H. Routh, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Loren W. Runnels, PhD
Full Member,
Cancer Metabolism and Growth Program

Alexey G. Ryazanov, PhD
Full Member,
Cancer Pharmacology Program

Hatem E. Sabaawy, MD, PhD
Full Member,
Cancer Pharmacology Program

Derek B. Sant'Angelo, PhD
Full Member,
Cancer Metabolism and Growth Program

Biren Saraiya, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Dipak K. Sarkar, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Armen P. Sarvazyan, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Dale G. Schaar, MD, PhD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Lee Ann Schein, PhD
Advisory Member,
Program: non-aligned

Karen A. Schindler, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Dona F. Schneider, PhD, MPH
Associate II Member,
Cancer Prevention and Control Program

Gertrud (Trudi) Schupbach, PhD
Full Member,
Cancer Metabolism and Growth Program

Jean E. Schwarzbauer, PhD
Full Member,
Cancer Metabolism and Growth Program

Kathleen W. Scotto, PhD
Full Member,
Cancer Pharmacology Program

Changshun Shao, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Archana Sharma, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Zhiyuan Shen, MD, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Thomas Shenk, PhD
Full Member,
Cancer Metabolism and Growth Program

Yufang Shi, DVM, MSc,PhD
Full Member,
Cancer Metabolism and Growth Program

Weichung (Joe) Shih, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Eric A. Singer, MD, MA
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Mona Singh, PhD
Full Member,
Cancer Metabolism and Growth Program

Rachana Singh, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Patrick J. Sinko, PhD, RPh
Full Member,
Cancer Pharmacology Program

Stavroula Sofou, PhD
Full Member,
Cancer Pharmacology Program

Eduardo D. Sontag, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Jerod Stapleton, PhD
Full Member,
Cancer Prevention and Control Program

Mark N. Stein, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Marc L. Steinberg, PhD
Full Member,
Cancer Prevention and Control Program

Michael B. Steinberg, MD, MPH, FACP
Full Member,
Cancer Prevention and Control Program

Ruth Steward, PhD
Full Member,
Cancer Metabolism and Growth Program

Ann M. Stock, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Roger K. Strair, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Randy S. Strich, PhD
Full Member,
Cancer Metabolism and Growth Program

Antoinette (Nan) M. Stroup, PhD
Full Member,
Cancer Prevention and Control Program

George P. Studzinski, MD, PhD
Full Member,
Cancer Pharmacology Program

Katsunori Sugimoto, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Nanjoo Suh, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Sujani G. Surakanti, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Zoltan Szekely, PhD
Associate II Member,
Cancer Pharmacology Program

Alfred F. Tallia, MD, MPH
Associate II Member,
Cancer Prevention and Control Program

XiangLin Tan, MD, PhD
Associate I Member,
Cancer Prevention and Control Program

TJ Thomas, PhD
Associate II Member,
Cancer Pharmacology Program

Bin Tian, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Jay A. Tischfield, PhD, FFACMG
Full Member,
Genome Instability and Cancer Genetics Program

Deborah L. Toppmeyer, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Olga Troyanskaya, PhD
Full Member,
Cancer Metabolism and Growth Program

Jennifer Tsui, PhD, MPH
Associate II Member,
Cancer Prevention and Control Program

Shuiping Tu, MD, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Kathryn E. Uhrich, PhD
Full Member,
Cancer Pharmacology Program

Michael P. Verzi, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Olivia A. Wackowski, PhD, MPH
Full Member,
Cancer Prevention and Control Program

Nancy C. Walworth, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Xiangbing Wang, MD, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Jennifer R. Warren, PhD, CTTS
Associate II Member,
Cancer Prevention and Control Program

Clifford P. Weisel, PhD
Full Member,
Program: non-aligned

Robert E. Weiss, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

William J. Welsh, PhD
Associate I Member,
Cancer Pharmacology Program

Eileen White, PhD
Full Member,
Cancer Metabolism and Growth Program

Ian P. Whitehead, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Robert Wieder, MD, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Eric F. Wieschaus, PhD
Full Member,
Cancer Metabolism and Growth Program

Jill M. Williams, MD
Full Member,
Cancer Prevention and Control Program

Lawrence J. Williams, PhD
Full Member,
Cancer Pharmacology Program

Rula Wilson, PhD, RN
Associate II Member,
Cancer Prevention and Control Program

Serena Wong, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Nancy Woychik, PhD
Full Member,
Program: non-aligned

Lizhao Wu, PhD
Associate II Member,
Genome Instability and Cancer Genetics Program

Bing Xia, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Mengqing Xiang, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Ping Xie, PhD
Full Member,
Cancer Metabolism and Growth Program

Chung S. Yang, PhD
Full Member,
Cancer Metabolism and Growth Program

Martin L. Yarmush, MD, PhD
Full Member,
Cancer Pharmacology Program

Guofeng You, PhD
Full Member,
Cancer Pharmacology Program

Ning Jeff Yue, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Edward (Ed) J. Yurkow, PhD
Associate II Member,
Cancer Pharmacology Program

Virginia A. Zakian, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Helmut Zarbl, PhD
Full Member,
Cancer Metabolism and Growth Program

Lanjing Zhang, MD, MS, FCAP, FASCP
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Miao Zhang, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

X. F. Steven Zheng, PhD
Full Member,
Cancer Pharmacology Program

Xi Zheng, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Hua Zhong, MD, PhD, FCAP
Advisory Member,
Clinical Investigations and Precision Therapeutics Program

Renping Zhou, PhD
Full Member,
Cancer Metabolism and Growth Program

Wei (Jennifer) Zou, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program